Tag: Melinta Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Melinta Therapeutics

Millennium Management LLC Buys Shares of 278915 Melinta Therapeutics (MLNT)

Added to Collection on: 2018-05-11 08:00:00

Tags for this article:

Chemistry
Organic chemistry
Melinta Therapeutics
Delafloxacin
Oritavancin

Click the tags to see associated articles and topics

View Article Details
Melinta Therapeutics (MLNT) Stock Rating Upgraded by WBB Securities

Added to Collection on: 2018-05-26 19:37:30

Tags for this article:

Economy
Chemistry
Financial analyst
Securities research
Organic chemistry
Melinta Therapeutics
Delafloxacin

Click the tags to see associated articles and topics

View Article Details
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

Added to Collection on: 2018-10-21 20:00:00

Tags for this article:

Health
Medicine
Chemistry
RTT
Antimicrobial resistance
Frank Vinluan
Melinta Therapeutics
Antibiotic
Michael Dudley
Penicillins
Enantiopure drugs
Carboxylic acids
Carbapenem antibiotics
Meropenem

Click the tags to see associated articles and topics

View Article Details
BioSpace Movers and Shakers: Dec. 26

Added to Collection on: 2018-12-21 04:10:26

Tags for this article:

Business
United States
Health
Biotechnology
Pfizer
CAC 40
Johnson & Johnson
Sanofi
Flatiron Health
Ablynx
Roche
Ionis Pharmaceuticals
Melinta Therapeutics
California Healthcare Institute

Click the tags to see associated articles and topics

View Article Details
Fosun International Ltd Takes $449000 Position in Melinta Therapeutics Inc (MLNT)

Added to Collection on: 2019-02-02 20:33:45

Tags for this article:

Economy of China
Chemistry
Organic chemistry
Fosun International
Melinta Therapeutics
Delafloxacin
melinta therapeutics, inc.

Click the tags to see associated articles and topics

View Article Details
Melinta Therapeutics' (MLNT) Buy Rating Reiterated at HC Wainwright

Added to Collection on: 2019-07-17 19:37:30

Tags for this article:

Money
Finance
Economy
Stock
Financial markets
Short
Corporate finance
Financial ratios
Financial regulation
Rate of return
Melinta Therapeutics
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Melinta Therapeutics (NASDAQ:MLNT) Issues Quarterly Earnings Results

Added to Collection on: 2019-08-10 21:41:15

Tags for this article:

Economy
Short
Financial regulation
Melinta Therapeutics
Delafloxacin
Antibiotic
Oritavancin
Chemical compounds
Organic compounds
Glycopeptide antibiotics

Click the tags to see associated articles and topics

View Article Details
Melinta Therapeutics and Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives ...

Added to Collection on: 2021-04-29 12:22:30

Tags for this article:

Chemical compounds
Chemistry
Drugs
Carboxylic acids
Hikma Pharmaceuticals
Meropenem
Oritavancin
Delafloxacin
HIK
Melinta Therapeutics
Hikma
Vaborbactam
Melinta TherapeuticsMelinta Therapeutics LLC
Hikma Pharmaceuticals PLC

Click the tags to see associated articles and topics

View Article Details
Antibiotic Resistance Markets Report 2021: New Technologies are Under Development to ...

Added to Collection on: 2021-09-01 13:41:15

Tags for this article:

Health sciences
Life Sciences
Health care
Pharmaceuticals policy
Antimicrobial resistance
Evolutionary biology
Veterinary medicine
AstraZeneca
AbbVie
Pfizer
Pharmaceutical industry in China
Melinta Therapeutics

Click the tags to see associated articles and topics

View Article Details
Antibiotic Resistance Market worth $18.34 Billion by 2030 - Exclusive Report by InsightAce Analytic

Added to Collection on: 2022-06-07 12:03:51

Tags for this article:

Health sciences
Life Sciences
Health care
Pharmaceuticals policy
Veterinary medicine
Antimicrobial resistance
Evolutionary biology
Bacteriophages
Phage therapy
Melinta Therapeutics
Antibiotic
Pfizer

Click the tags to see associated articles and topics

View Article Details